Hypertension Clinical Trial
Official title:
Prevalence of Chronic KIdney Disease in Hypertensive Patients
Prevention of progressive renal disease needs a clear understanding of prevalence of early stage of chronic kidney disease in a community. Even in developed countries most subjects in early stages of chronic kidney disease go largely undiagnosed and untreated. Targeted screening could identify a greater numbers of individuals at risk then a general public screening (11). It is economically more feasible to perform in a country like Pakistan. Hypertension and diabetes are highly prevalent in South-Asia.It is anticipated that if target screening of hypertensive population is performed especially of an age group in which intervention might be expected to have maximal benefit it will not only help to identify from a large number of patients with essential hypertension destined to develop or in the course of advancing towards end stage renal disease but will also unearth mislabeled “essential hypertension” that have underlying primary renal disease. This later group may belong to socio-economic disadvantaged population who have limited access to health care and have never been investigated properly. The aim of the Study is to detect sub-clinical chronic kidney disease in hypertensive patients at community level and to identify associated risk factors.
This will be Cross sectional or prevalent study targeting diagnosed hypertensives aged 40
and above years, in middle to low socio-economic settings of Karachi. This proposed study
will be nested in the existing Wellcome Trust funded study. The parent study is designed to
determine the impact of a unique community versus high risk approach to control BP in
Karachi, Pakistan In that ongoing Factorial design, individuals aged ≥40 who are found
hypertensive in the 12 clusters (each containing 250 households) are being randomized to
different interventions for their BP control. All participants enrolled in that study had
urine examination for proteinuria and serum creatinine measurements at baseline to assess
their renal status. For the proposed study the identified hypertensive (from parent study)
who had either shown proteinuria and or had elevated serum creatinine (more then 1.2 for
females and 1.4 mg/dl for males) at baseline will be approached. Serum creatinine levels
exceeding above mentioned cut-off levels, are only reached when GFR is<60ml/min/m². As
mentioned above in order to classify these subjects as having chronic kidney disease these
abnormalities must be demonstrated to persist for at least three months. A repeat serum
creatinine measurement and urine examination for proteinuria will be performed in the
present study, by obtaining blood sample and urine sample respectively from these subjects.
As a period of three months have already passed since the baseline investigations were done,
all subjects who will show persistent abnormalities in either or both test will fall into
chronic kidney disease group. The repeated testing to confirm presence of CKD will include,
measurement of serum creatinine and urinary albumin/creatinine ratio (>30mg/g) in an untimed
urine specimen. This method has been recommended as the preferred screening strategy. A set
questionnaire will be filled by interviewing the patient and risk factors for the presence
of renal disease will be analyzed based on this information.
The data collection will be done through structured questionnaire and diagnosis will be made
on the basis of their persistently elevated kidney biomarkers.
;
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |